Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma might help treat eczema by reducing inflammation and repairing the skin.

Inflammation plays a key role in activating skin stem cells for hair growth and wound healing, but more research is needed to understand how it directs cell behavior.

Histone modification is key in treating chronic inflammatory skin diseases.

Different cells affect hair follicle blood vessels, endothelial cells react differently to inflammation and oxidized fats, and prasugrel better protects heart vessels during a procedure than clopidogrel.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

An 8-year-old girl developed a rare skin condition in a linear pattern on one side of her body after a lung infection, which improved with treatment.

Syphilitic alopecia is a rare hair loss condition in secondary syphilis that looks similar to another condition but can be diagnosed with specific tests and responds to antibiotics.

The Nd:YAG laser is a successful and safe way to treat ingrown and pincer nails.

Hair loss in black women needs more research, early intervention, and community education.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

A horse with severe hair loss was diagnosed with alopecia areata and a yeast infection.

Platelet-rich plasma therapy may help treat folliculitis decalvans but benefits might not last without ongoing treatment.

A young man with an unusual type of scarring hair loss suggests a possible new variant of a known scalp condition.

Lichen planus pigmentosus and fibrosing frontal alopecia in Colombia are likely different stages of the same disease.

Tufted folliculitis is common in patients with folliculitis decalvans.

CCCA is a common, progressive hair loss condition that may not always be linked to hair care practices and requires a biopsy for diagnosis.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

Managing frontal fibrosing alopecia and lichen planus pigmentosus is challenging due to resistant hair loss and skin discoloration.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

The document concludes that treatment can improve hair growth and symptoms in Fibrosing Alopecia in a Pattern Distribution.

CCCA and LPP may be related hair loss conditions influenced by genetics and environment, needing early treatment.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.